Antibody to Certolizumab Pegol ELISA

Enzyme immunoassay for the semi-quantitative determination of free antibodies to Certolizumab Pegol (Cimzia®) in serum and plasma.

The solid phase (MTP) is coated by the drug Certolizumab Pegol. Due to the assay design this test only measures the free antibodies which are not bound to Certolizumab Pegol. Results are expressed in AU (arbitrary units).

Reference: IG-BB109

Barcode: 8699316552413

Legal Status: CE Mark

Intended Use: This kit has been developed for the detection of anti-drug antibodies in research and diagnostic uses. It is suitable for Therapeutical Drug Monitoring (TDM) purposes.

Assay Design:

IG-BB109

Related Documents

 

Quality Control Certificates

Cimzia® is a trademark of  UCB.

The Kit at a glance:

Required Volume (µL)  10
Incubation Time (min) 165
Sample Serum or Plasma
Package Size 96 Tests
Results in Arbitrary Units (AU/mL)
Cut-Off (AU/mL) 3
Shelf Life (years) 2